Navigation Links
Tumor in Bone Shows Neanderthals Got Cancer Too
Date:6/6/2013

THURSDAY, June 6 (HealthDay News) -- Cancer is often lamented as a modern-day scourge, but researchers have discovered a type of bone cancer in a 120,000-year-old Neanderthal rib.

Before this discovery was made in Krapina, Croatia, the earliest evidence of this type of bone tumor, known as fibrous dysplasia, dated back 1,000 to 4,000 years.

The researchers, who reported the finding online June 5 in the journal PLoS One, said the specimen found is incomplete so they can't determine the effects the tumor had on the Neanderthal's overall health.

"Evidence for cancer is extremely rare in the human fossil record," David Frayer, of the University of Kansas, said in a journal news release. "This case shows that Neanderthals, living in an unpolluted environment, were susceptible to the same kind of cancer as living humans."

The average lifespan of Neanderthals was likely about half that of humans in developed countries today, and they were exposed to a different environment, the researchers said.

"Given these factors, cases of neoplastic disease are rare in prehistoric human populations," the researchers said. "Against this background, the identification of a more than 120,000-year-old Neanderthal rib with a bone tumor is surprising, and provides insights into the nature and history of the association of humans to neoplastic disease."

Fibrous dysplasia is more common today than other bone tumors, Frayer said.

More information

The American Academy of Orthopaedic Surgeons provides more information on fibrous dysplasia.

-- Mary Elizabeth Dallas

SOURCE: Public Library of Science, news release, June 5, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Improved Stem Cell Line May Avoid Tumor Risk: Study
2. Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
3. Dental X-Rays May Be Linked to Benign Brain Tumors
4. Live imaging shows response to cancer drugs can be boosted by altering tumor microenvironment
5. Brain Tumor Vaccine Shows Promise in Early Trial
6. Kidney Cancer Patients Fare Better With Tumor Removal Only
7. IBN discovers human neural stem cells with tumor targeting ability
8. Protein prevents DNA damage in the developing brain and might serve as a tumor suppressor
9. Small molecular bodyguards kill HPV-infected cancer cells by protecting tumor-suppressor
10. New surgical technique for removing inoperable tumors of the abdomen
11. Combination of 2 drugs reverses liver tumors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Tumor in Bone Shows Neanderthals Got Cancer Too
(Date:1/23/2017)... ... January 23, 2017 , ... ... Society of Anesthesiologists® (ASA®), the Foundation for Anesthesia Education and Research (FAER), ... (AAOS) and the Cigna Foundation, encourages proposals supporting high quality research using ...
(Date:1/23/2017)... ... 2017 , ... “The Inn at the Mill”: a story of love and redemption, hope ... become happy and content. , “The Inn at the Mill” is the creation of ... and Vermont and is now living in Berks County on Crow Hill. The ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... launched online education programs and resources at seafoodnutrition.org/programs and seafoodnutrition.org/resources to assist ... a seafood-rich diet. These resources have been developed for use by nutrition ...
(Date:1/23/2017)... ... ... Infallible Characteristics of Christ”: a fascinating and entrancing novel exploring the gifts and ... author, Rev. Dr. Robert W. Thomas, the third of seven siblings. He was a ... pastor for over fifteen years. He is a graduate of N.C. College of Theology ...
(Date:1/22/2017)... MALO, FRANCE (PRWEB) , ... January 22, 2017 , ... ... Indian Ocean, isolated from the rest of the world with ZANZIBAR MILKY CREAM. Inspired ... Phytocéane used key ingredients like Virgin Coconut Oil and moisturizing vegetal coral to create ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... SAN DIEGO and PALMA, ... Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical ... announced that the first patient has been enrolled ... of lead candidate, SNF472, for the treatment of ... haemodialysis (HD). Most ESRD patients, in ...
(Date:1/21/2017)... 20, 2017 Research and Markets has ... Market By Type of Test (Tumor, Clinical Chemistry, Microbiology, Esoteric), ... of Diseases (Tuberculosis, Influenza, Cancer, HIV/AIDS etc.), Forecast to 2022" ... ... healthcare services, market segments, especially clinical lab testing, which has ...
(Date:1/21/2017)... Jan 20, 2017 Research and Markets has ... & Trends - Technology, Route Of Administration, End User - Forecast ... ... poised to grow at a CAGR of around 7.8% over the ... This industry report analyzes the global markets for Advanced Drug ...
Breaking Medicine Technology: